Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002328080 | SCV002629649 | uncertain significance | Cardiovascular phenotype | 2020-08-03 | criteria provided, single submitter | clinical testing | The p.S14094I variant (also known as c.42281G>T), located in coding exon 152 of the TTN gene, results from a G to T substitution at nucleotide position 42281. The serine at codon 14094 is replaced by isoleucine, an amino acid with dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Gene |
RCV005370205 | SCV005921661 | uncertain significance | not provided | 2024-10-17 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Missense variant in a gene in which most reported pathogenic variants are truncating/loss of function; Has not been previously published as pathogenic or benign to our knowledge |